Development of CCK-tetrapeptide analogues as potent and selective CCK-A receptor agonists.
Neuroscience Research Division, Abbott Laboratories, Abbott Park, Illinois 60064.
K
K
Shiosaki
C W
CW
Lin
H
H
Kopecka
R
R
Craig
F L
FL
Wagenaar
B
B
Bianchi
T
T
Miller
D
D
Witte
A M
AM
Nadzan
D000595:Amino Acid Sequence; D000681:Amylases / Q000378:metabolism; D000818:Animals; D002540:Cerebral Cortex / Q000378:metabolism; D002766:Cholecystokinin / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology; D006168:Guinea Pigs; D008969:Molecular Sequence Data; D015394:Molecular Structure; D009842:Oligopeptides / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism; D010446:Peptide Fragments / Q000138:chemical synthesis / Q000378:metabolism* / Q000494:pharmacology; D011949:Receptors, Cholecystokinin / Q000187:drug effects / Q000378:metabolism*; D013329:Structure-Activity Relationship; D013758:Tetragastrin / Q000031:analogs & derivatives*
D009842:Oligopeptides; D010446:Peptide Fragments; D011949:Receptors, Cholecystokinin; D013758:Tetragastrin; C066278:A 71623; D002766:Cholecystokinin; D000681:Amylases